TissueVision, Inc

TissueVision, Inc is a multi-disciplinary life sciences company that specializes in offering 3D tissue imaging and analysis solutions to the research market. Their innovative Serial Two-Photon Plus (STP²) platform provides high-resolution multispectral datasets and analysis pipelines, enabling the creation of reliable 3D tissue models. TissueVision, Inc. also offers secondary analyses and advanced spatial genomics, resulting in rich, multiplexed 3D models that deliver actionable and quantitative results. Founded in 2005, the company is headquartered in the United States and operates primarily in the biotechnology industry.

The company's solutions cater to a wide range of therapeutic areas, including neuroscience, cancer, neurodegeneration, ophthalmology, and dermatology. TissueVision, Inc. additionally provides project design, GLP-like documentation, protocol and report generation, and quality control review measures for all study-related materials.

Although specific details regarding the last investment and investors are not available at the moment, TissueVision, Inc. presents a compelling opportunity for venture capitalists seeking to invest in advanced life sciences technologies with diverse applications and a proven track record in the industry.